Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX NYSE:DVA NYSE:LH NYSE:OCR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$177.09+1.6%$174.20$146.17▼$182.38$19.79B0.461.42 million shs616,268 shsDVADaVita$129.55+1.5%$140.02$126.07▼$179.60$9.26B1.09883,366 shs949,567 shsLHLabcorp$266.07+2.4%$257.69$209.38▼$283.47$22.09B0.78836,385 shs555,186 shsOCROmnicare$0.00$0.00▼$0.00N/AN/AN/AN/A10 Stocks Set to Soar in Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics0.00%+3.67%+3.26%+0.07%+21.18%DVADaVita0.00%-6.42%-9.64%-9.80%-3.39%LHLabcorp0.00%+1.81%+5.10%+8.26%+21.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.7437 of 5 stars1.35.04.24.72.92.52.5DVADaVita4.7861 of 5 stars3.02.00.04.52.02.54.4LHLabcorp4.6743 of 5 stars2.34.02.54.23.62.51.9OCROmnicareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.67Moderate Buy$186.005.03% UpsideDVADaVita 2.00Hold$164.0026.59% UpsideLHLabcorp 2.62Moderate Buy$289.588.84% UpsideOCROmnicare 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest OCR, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$148.008/7/2025DVADaVitaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$169.00 ➝ $160.007/25/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$282.00 ➝ $305.007/25/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$290.00 ➝ $310.007/25/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$285.00 ➝ $300.007/25/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$283.00 ➝ $306.007/25/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $302.007/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$185.007/23/2025DGXQuest DiagnosticsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform7/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$190.00 ➝ $192.007/23/2025DGXQuest DiagnosticsDeutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$160.00 ➝ $178.00(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B2.01$13.52 per share13.10$64.97 per share2.73DVADaVita$12.82B0.72$19.14 per share6.77($1.51) per share-85.80LHLabcorp$13.01B1.70$22.42 per share11.87$101.96 per share2.61OCROmnicareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$8.3521.2116.882.359.01%15.24%6.64%10/28/2025 (Estimated)DVADaVita$936.34M$10.1712.7410.190.896.35%369.39%4.62%N/ALHLabcorp$746M$9.0629.3715.171.705.66%15.45%7.02%10/23/2025 (Estimated)OCROmnicareN/AN/A0.00N/AN/AN/AN/AN/AN/ALatest OCR, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025DVADaVita$2.70$2.95+$0.25$2.58$3.36 billion$3.38 billion7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billion5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.81%N/A38.32%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.08%N/A31.79%N/AOCROmnicareN/AN/AN/AN/AN/ALatest OCR, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/20255/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.711.090.99DVADaVita23.181.391.20LHLabcorp0.611.501.32OCROmnicareN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%OCROmnicareN/AInsider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%DVADaVita2.00%LHLabcorp0.84%OCROmnicareN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDVADaVita76,00071.50 million70.07 millionOptionableLHLabcorp70,00083.10 million82.40 millionOptionableOCROmnicareN/AN/AN/ANot OptionableOCR, LH, DGX, and DVA HeadlinesRecent News About These CompaniesOmnicare Whistleblower Won’t Collect in Federal CourtMay 15, 2024 | courthousenews.comCPythagoras' theorem - OCRApril 24, 2024 | bbc.co.ukTransformation of curves - Higher - OCRMarch 19, 2024 | bbc.co.ukSample exam questions - interacting with Earth systems - OCR GFebruary 29, 2024 | bbc.co.ukRadioactivity - OCR Gateway RadiationFebruary 28, 2024 | bbc.co.ukHHS Delivers Reports to Congress on HIPAA Compliance, EnforcementFebruary 27, 2024 | healthitsecurity.comHThe mobilisation of the US people during World War Two - OCR AFebruary 23, 2024 | bbc.co.ukHistory - OCR AFebruary 23, 2024 | bbc.co.ukBritain since c.1900 and the people's health - OCR BFebruary 23, 2024 | bbc.co.ukUnits and data representation - OCRFebruary 18, 2024 | bbc.co.ukEnergy, temperature and change of state - OCR GatewayFebruary 15, 2024 | bbc.co.ukForces and elasticity - OCR GatewayFebruary 10, 2024 | bbc.co.ukNature of human life - OCRFebruary 10, 2024 | bbc.co.ukSolving simultaneous equations - OCRFebruary 6, 2024 | bbc.co.ukLight - OCR Gateway ColourFebruary 5, 2024 | bbc.co.ukRefugees and ‘enemy aliens’ in the Modern Era, 1900 - 1947 - OCR BFebruary 3, 2024 | bbc.co.ukWhole numbers - OCR Order of operationsFebruary 2, 2024 | bbc.co.ukWhat determines the current in an electric circuit? - OCR 21st CenturyJanuary 22, 2024 | bbc.co.ukSupplying the cell - OCR GatewayJanuary 20, 2024 | bbc.co.ukSample exam questions - organism level systems - OCR GatewayJanuary 20, 2024 | bbc.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonWhy the American Eagle Stock Rally Isn't Just Speculation By Gabriel Osorio-Mazilli | July 28, 2025View Why the American Eagle Stock Rally Isn't Just Speculation This Drone Stock Is on Sale Despite Big Army ContractBy Jeffrey Neal Johnson | July 31, 2025View This Drone Stock Is on Sale Despite Big Army ContractAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings?By Jordan Chussler | July 23, 2025View Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings?OCR, LH, DGX, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$177.08 +2.82 (+1.62%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$176.97 -0.12 (-0.06%) As of 08/8/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$129.55 +1.86 (+1.46%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$129.54 -0.01 (-0.01%) As of 08/8/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$266.07 +6.11 (+2.35%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$265.83 -0.24 (-0.09%) As of 08/8/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Omnicare NYSE:OCROmnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.